Susan Abushakra

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval”.

Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00663-w

N/A

0DataRank · unranked

357 citations

Susan Abushakra, John A. Hey, Anton P. Porsteinsson, Marwan N. Sabbagh, Martin Tolar

APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics

Alzheimer s & Dementia Translational Research & Clinical Interventions(2024)10.1002/trc2.12498

N/A

0DataRank · unranked

22 citations

Anton P. Porsteinsson, Marwan Sabbagh, David Watson, Aidan Power, Earvin Liang +8 more